search
Back to results

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes (AWARD-11)

Primary Purpose

Diabetes Mellitus, Type 2

Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
Dulaglutide
Sponsored by
Eli Lilly and Company
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 2

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Have type 2 diabetes mellitus (T2DM) for at least 6 months
  • Have been treated with stable metformin dose for at least 3 months
  • Have HbA1c ≥7.5% and ≤11.0% at study entry
  • Have body mass index (BMI) ≥25 kilograms per meter squared (kg/m^2)

Exclusion Criteria:

  • Have type 1 diabetes mellitus
  • Have used any glucagon-like peptide-1 receptor agonist (GLP-1 RA) or insulin, not including prior short term insulin use (≤14 days)
  • Have been taking any other medicine for diabetes (other than metformin) during the last 3 months
  • Have used in the last 3 months (or plan to use) prescription weight loss medications
  • Have disorders associated with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss
  • Current participation in or intent to begin during the study an organized diet and/or exercise weight reduction program (other than the lifestyle and dietary measures for diabetes)
  • Have acute or chronic hepatitis, signs and symptoms of any other liver disease other than nonalcoholic fatty liver disease (NAFLD), or alanine transaminase (ALT) level >2.5 times the upper limit of the reference range, as determined by the central laboratory at study entry; participants with NAFLD are eligible for participation in this trial
  • Had chronic or acute pancreatitis any time prior to study entry
  • Have had a heart attack or stroke in the past 2 months, or have heart failure that significantly limits their physical activity
  • Estimated glomerular filtration rate (eGFR) <30 milliliters/minute/1.73m^2 (or lower than the country-specific threshold for discontinuing metformin therapy per local label), calculated by the Chronic Kidney Disease-Epidemiology (CKD-EPI) equation, as determined by the central laboratory at study entry and confirmed at lead-in
  • Have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2
  • Have proliferative retinopathy or maculopathy requiring acute treatment according to the opinion of the investigator

Sites / Locations

  • Synexus- Chandler
  • Synexus/Central Arizona Medical Associates, PC
  • Central Phoenix Med Clinic LLC
  • Arkansas Clinical Research
  • Anaheim Clinical Trials, LLC
  • Valley Research
  • National Research Institute
  • National Research Institute
  • Catalina Research Institute, LLC
  • Valley Clinical Trials, Inc.
  • Pacific Research Partners, LLC
  • National Research Institute
  • Sierra Clinical Research
  • Artemis Institute for Clinical Research
  • Care Access Research
  • Encompass Clinical Research
  • University Clinical Investigators, Inc.
  • Diablo Clinical Research
  • Chase Medical Research, LLC
  • ALL Medical Research, LLC
  • Clinical Research of South Florida
  • Suncoast Research Group, LLC
  • New Horizon Research Center
  • Oviedo Medical Research
  • Urban Family Practice Associates, PC
  • In-Quest Medical Research, LLC- Peachtree Corners
  • Pacific Diabetes & Endocrine Center
  • East West Medical Institute
  • Elite Clinical Trials LLLP
  • Saltzer Medical Group. P.A.
  • Prairie Education and Research Cooperative
  • Synexus/Clinical Research Advantage
  • Midwest Institute for Clinical Research
  • Iderc, P.L.C.
  • InterMed, PA
  • MedStar Health Research Institute
  • NECCR PrimaCare Research, LLC
  • Aa Mrc Llc
  • Troy Internal Medicine, PC
  • Clinical Research Professionals
  • StudyMetrix Research, LLC
  • Montana Health Research
  • Glacier View Research Institute
  • Premier Research
  • Manhattan Medical Research
  • Great Lakes Medical Research
  • Metrolina Internal Medicine, P.A.
  • Diabetes & Endocrinology Consultants PC
  • Aventiv Research
  • Intend Research
  • IPS Research Company
  • The Corvallis Clinic P.C.
  • Summit Research Network Inc
  • Heritage Valley Medical Group, Inc.
  • Detweiler Family Medicine
  • Preferred Primary Care Physicians
  • Sudir Bansal M.D. Inc.
  • PMG Research of Charleston, LLC
  • Chattanooga Research and Medicine (CHARM)
  • Dallas Diabetes Endocrine Center
  • Southern Endocrinology and Associates PA
  • Consano Clinical Research
  • Martin Diagnostic Clinic
  • ClinPoint Trials, LLC
  • Progressive Clinical Research
  • Advanced Research Institute
  • Manassas Clinical Research Center
  • Clinical Research Partners, LLC
  • Capital Clincial Research Center
  • Walla Walla Clinic
  • Wenatchee Valley Hospital & Clinics
  • Prevea Clinic, Inc
  • Centro Medico CICEMO
  • CEDIC-Centro de Investigaciones Clinicas
  • Investigaciones Medicas IMOBA S.R.L.
  • Centro de Investigaciones Metabólicas (CINME)
  • Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada
  • Centro de Investigacion y Prevencion Cardiovascular (CIPREC)
  • Instituto de Investigaciones Clinicas Mar del Plata
  • CIPADI
  • AXISMED SRL - Bioclinica Research Network
  • CENUDIAB
  • Centro Médico Viamonte
  • Instituto Centenario
  • Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
  • Mautalen Salud e Investigación - Servicio de Endocrinología
  • Instituto Medico Strusberg
  • Centro Medico Privado San Vicente Diabetes
  • Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC
  • Landesklinikum Korneuburg-Stockerau, Standort Stockerau
  • Universitätsklinikum Graz
  • Ordination Dr. Evelyn Fließer-Görzer
  • VIVIT Institut am LKH Feldkirch
  • KA Rudolfstiftung
  • Zentrum für klinische Studien Dr. Ursula Hanusch GmbH
  • Bailey Clinic
  • Aggarwal and Associates Ltd
  • T. Nemtean Medicine Professional Corporation
  • Bluewater Clinical Research Group Inc
  • Stayner Medical Clinic
  • Dr. Anil K. Gupta Medicine Professional Corporation
  • Iatriko Palaiou Falirou, Medical Center
  • Laiko General Hospital of Athens
  • Gen Hospital of Athens G Gennimatas
  • G.Papanikolaou General Hospital
  • Thermi Clinic
  • Athens Euroclinic
  • University General Hospital of Larissa
  • AHEPA Hospital
  • Ippokrateio General Hospital of Thessaloniki
  • Euromedica - General Clinic of Thessaloniki
  • Studium Egeszseghaz Kft.
  • Kenezy Gyula Korhaz es Rendelointezet
  • Grof Esterhazy Korhaz es Rendelointezeti Szakrendelo
  • Szent Margit Rendelointezet
  • ClinDiab Kft.
  • Strazsahegy Medicina Bt.
  • TRANTOR 99 Bt.
  • Kanizsai Dorottya Korhaz
  • Zala Megyei Szent Rafael Korhaz
  • Maccabi Diabetes Clinic, Grand Canyon, North District, Haifa
  • Linn Medical Center
  • Hadassah Medical Center
  • Meir Medical Center
  • Clalit Health Services - Shuali Clinic
  • ZIV Medical Center
  • Sakhnin Community Clinic, Clalit Health Services
  • Tel Aviv Sourasky Medical Center
  • Diabetes Medical Center (DMC)
  • Azienda Ospedaliera Universitaria Careggi
  • Istituto Clinico Humanitas
  • A.O.U. Senese Policlinico Santa Maria alle Scotte
  • Azienda Ospedaliera Papa Giovanni XXIII
  • Policlinico Mater Domini
  • Fondazione Universitaria degli Studi G D'Annunzio
  • Ospedale Santa Maria Goretti
  • Policlinico Giaccone
  • Ospedale Civile Maggiore Borgo Trento
  • Hospital Univ. Dr. Jose Eleuterio Gonzalez
  • Investigacion en Salud y Metabolismo S.C
  • NZOZ ZDROWIE Osteo-Medic
  • Poradnia Diabetologiczna SN ZOZ Lege Artis
  • NS ZOZ Osrodek Diabetologiczny " Popula"
  • Centrum Badan Klinicznych, PI House
  • NZOZ Salvia s.c.
  • NZOZ Diab-Endo-Met
  • Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A.
  • Gabinety Terpa
  • NZOZ Przychodnia Specjalistyczna MEDICA
  • Centrum Medyczne OMEDICA
  • Praktyka Lekarska
  • Nzoz Neuro - Kard
  • NZOZ Przychodnia Specjalistyczna Henryk RudzkiAndrzej Wittek
  • Centralny Szpital Kliniczny MSW
  • Regionalna Poradnia Diabetologiczna
  • Research and Cardiovascular Corp.
  • Clinical Research Puerto Rico, Inc.
  • GCM Medical Group PSC
  • Office: Dr. Luis Rivera Colon
  • S. C. Grandmed S.R.L., Str.
  • SC Gama Diamed SRL
  • Spitalul Judetean de Urgenta Satu Mare
  • CMI DNBM Dr. Pop Lavinia
  • Cosamext SRL
  • SC Diabmed Dr Popescu Alexandrina SRL
  • SC Dianutrilife Medica SRL
  • Centrul Medical Dr. Negrisanu
  • Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL
  • Cabinetul Medical Nicodiab SRL
  • Easydiet SRL
  • SC Nutrilife SRL
  • SC Medcon SRL
  • Centrul Medical Unirea SRL
  • Cabinet Medical Urodiamed S.R.L.
  • Milena Sante SRL
  • SC Olimpia Med SRL
  • Arkhangelsk Regional Clinical Hospital
  • Arkhangelsk the first city clinical hospital
  • Rostov State Medical University
  • City Hospital of Saint Martyr Elizabeth
  • SPb GUZ "Diagnostic Center #85"
  • Regional Clinical Hospital
  • Human care s.r.o.
  • MediVet s.r.o.
  • Areteus s.r.o.
  • Diacrin s.r.o.
  • Noemis, s.r.o.
  • FUNKYSTUFF s.r.o.
  • MUDr. Jan Culak, s.r.o.
  • DIA-MED CENTRUM s.r.o.
  • Tatratrial s.r.o.
  • Hospital Infanta Luisa
  • Corporació Sanitaria Parc Tauli
  • Hospital Universitario Marques De Valdecilla
  • Clinica Juaneda
  • Hospital Universitario Quiron Madrid
  • Instituto de Ciencias medicas
  • Clinica San Pedro
  • Centre Medico Teknon
  • Hospital Clinico Universitario San Cecilio
  • Virgen de Las Nieves
  • Centro Especialidades San Jose Obrero (Barbarela)
  • Hospital Universitario Virgen Macarena
  • Clinica Nuevas Tecnologias en Diabetes y Endocrinologia
  • Policlinica Galileo
  • Chung Shan Medical University Hospital
  • Taichung Veterans General Hospital
  • Chi-Mei Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Experimental

Experimental

Arm Label

Dulaglutide 1.5 mg

Dulaglutide 3 mg

Dulaglutide 4.5 mg

Arm Description

Dulaglutide 1.5 mg administered subcutaneously (SC) once a week.

Dulaglutide 3 mg administered SC once a week.

Dulaglutide 4.5 mg administered SC once a week.

Outcomes

Primary Outcome Measures

Change in Hemoglobin A1c (HbA1c) From Baseline
HbA1c is measured to identify average plasma glucose concentration over prolonged periods of time. The Least Squares (LS) mean was estimated from a mixed-effects model with repeated measures (MMRM) that included the independent variables:Baseline + Pooled Country + Treatment + Time + Treatment*Time (Type III sum of squares).

Secondary Outcome Measures

Change in Body Weight From Baseline
Least Squares (LS) mean was determined by mixed-model repeated measures (MMRM) model with independent variables: Baseline + Baseline HbA1c group + Pooled Country + Treatment + Time + Treatment*Time (Type III sum of squares).
Percentage of Participants Achieving HbA1c Target <7.0%
Percentage of participants achieving HbA1c target <7.0%.
Change in Fasting Serum Glucose (FSG) From Baseline
Least Squares (LS) mean was determined by mixed-model repeated measures (MMRM) model with covariates: Baseline + Baseline HbA1c group + Pooled Country + Treatment + Time + Treatment*Time (Type III sum of squares).
Rate of Documented Symptomatic Hypoglycemic Episodes
Hypoglycemia was defined as blood glucose < 54 mg/dL, excluding post-rescue records. Estimate is based on Group Mean from negative binomial model. The negative binomial model for post-baseline comparisons between treatments and control group: Number of episodes = Pooled Country + HbA1c at Baseline (%) + Treatment, with log (exposure in days/365.25) as an offset variable.
Pharmacokinetic (PK): Steady-state Maximum Concentration(Cmax,ss)
Pharmacokinetic (PK): Steady-state Maximum Concentration(Cmax,ss).
Pharmacokinetic (PK): Area Under the Curve AUC (0-168)ss at Steady State
Pharmacokinetic (PK): Area Under the Curve AUC (0-168)ss at Steady State.

Full Information

First Posted
April 2, 2018
Last Updated
May 28, 2020
Sponsor
Eli Lilly and Company
search

1. Study Identification

Unique Protocol Identification Number
NCT03495102
Brief Title
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes
Acronym
AWARD-11
Official Title
A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Study Type
Interventional

2. Study Status

Record Verification Date
December 15, 2019
Overall Recruitment Status
Completed
Study Start Date
April 5, 2018 (Actual)
Primary Completion Date
May 28, 2019 (Actual)
Study Completion Date
October 10, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Eli Lilly and Company

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to evaluate the efficacy and safety of investigational doses of once weekly dulaglutide when added to metformin in participants with type 2 diabetes with inadequate blood sugar control.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 2

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
1842 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dulaglutide 1.5 mg
Arm Type
Active Comparator
Arm Description
Dulaglutide 1.5 mg administered subcutaneously (SC) once a week.
Arm Title
Dulaglutide 3 mg
Arm Type
Experimental
Arm Description
Dulaglutide 3 mg administered SC once a week.
Arm Title
Dulaglutide 4.5 mg
Arm Type
Experimental
Arm Description
Dulaglutide 4.5 mg administered SC once a week.
Intervention Type
Drug
Intervention Name(s)
Dulaglutide
Other Intervention Name(s)
LY2189265
Intervention Description
Administered SC
Primary Outcome Measure Information:
Title
Change in Hemoglobin A1c (HbA1c) From Baseline
Description
HbA1c is measured to identify average plasma glucose concentration over prolonged periods of time. The Least Squares (LS) mean was estimated from a mixed-effects model with repeated measures (MMRM) that included the independent variables:Baseline + Pooled Country + Treatment + Time + Treatment*Time (Type III sum of squares).
Time Frame
Baseline, Week 36
Secondary Outcome Measure Information:
Title
Change in Body Weight From Baseline
Description
Least Squares (LS) mean was determined by mixed-model repeated measures (MMRM) model with independent variables: Baseline + Baseline HbA1c group + Pooled Country + Treatment + Time + Treatment*Time (Type III sum of squares).
Time Frame
Baseline, Week 36
Title
Percentage of Participants Achieving HbA1c Target <7.0%
Description
Percentage of participants achieving HbA1c target <7.0%.
Time Frame
Week 36
Title
Change in Fasting Serum Glucose (FSG) From Baseline
Description
Least Squares (LS) mean was determined by mixed-model repeated measures (MMRM) model with covariates: Baseline + Baseline HbA1c group + Pooled Country + Treatment + Time + Treatment*Time (Type III sum of squares).
Time Frame
Baseline, Week 36
Title
Rate of Documented Symptomatic Hypoglycemic Episodes
Description
Hypoglycemia was defined as blood glucose < 54 mg/dL, excluding post-rescue records. Estimate is based on Group Mean from negative binomial model. The negative binomial model for post-baseline comparisons between treatments and control group: Number of episodes = Pooled Country + HbA1c at Baseline (%) + Treatment, with log (exposure in days/365.25) as an offset variable.
Time Frame
Week 36
Title
Pharmacokinetic (PK): Steady-state Maximum Concentration(Cmax,ss)
Description
Pharmacokinetic (PK): Steady-state Maximum Concentration(Cmax,ss).
Time Frame
Week 4, Week 12, Week 36, Week 52
Title
Pharmacokinetic (PK): Area Under the Curve AUC (0-168)ss at Steady State
Description
Pharmacokinetic (PK): Area Under the Curve AUC (0-168)ss at Steady State.
Time Frame
Week 4, Week 12, Week 36, Week 52

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Have type 2 diabetes mellitus (T2DM) for at least 6 months Have been treated with stable metformin dose for at least 3 months Have HbA1c ≥7.5% and ≤11.0% at study entry Have body mass index (BMI) ≥25 kilograms per meter squared (kg/m^2) Exclusion Criteria: Have type 1 diabetes mellitus Have used any glucagon-like peptide-1 receptor agonist (GLP-1 RA) or insulin, not including prior short term insulin use (≤14 days) Have been taking any other medicine for diabetes (other than metformin) during the last 3 months Have used in the last 3 months (or plan to use) prescription weight loss medications Have disorders associated with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss Current participation in or intent to begin during the study an organized diet and/or exercise weight reduction program (other than the lifestyle and dietary measures for diabetes) Have acute or chronic hepatitis, signs and symptoms of any other liver disease other than nonalcoholic fatty liver disease (NAFLD), or alanine transaminase (ALT) level >2.5 times the upper limit of the reference range, as determined by the central laboratory at study entry; participants with NAFLD are eligible for participation in this trial Had chronic or acute pancreatitis any time prior to study entry Have had a heart attack or stroke in the past 2 months, or have heart failure that significantly limits their physical activity Estimated glomerular filtration rate (eGFR) <30 milliliters/minute/1.73m^2 (or lower than the country-specific threshold for discontinuing metformin therapy per local label), calculated by the Chronic Kidney Disease-Epidemiology (CKD-EPI) equation, as determined by the central laboratory at study entry and confirmed at lead-in Have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2 Have proliferative retinopathy or maculopathy requiring acute treatment according to the opinion of the investigator
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Organizational Affiliation
Eli Lilly and Company
Official's Role
Study Director
Facility Information:
Facility Name
Synexus- Chandler
City
Chandler
State/Province
Arizona
ZIP/Postal Code
85224
Country
United States
Facility Name
Synexus/Central Arizona Medical Associates, PC
City
Mesa
State/Province
Arizona
ZIP/Postal Code
85206
Country
United States
Facility Name
Central Phoenix Med Clinic LLC
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85020
Country
United States
Facility Name
Arkansas Clinical Research
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72205
Country
United States
Facility Name
Anaheim Clinical Trials, LLC
City
Anaheim
State/Province
California
ZIP/Postal Code
92801
Country
United States
Facility Name
Valley Research
City
Fresno
State/Province
California
ZIP/Postal Code
93720
Country
United States
Facility Name
National Research Institute
City
Huntington Park
State/Province
California
ZIP/Postal Code
90255
Country
United States
Facility Name
National Research Institute
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Facility Name
Catalina Research Institute, LLC
City
Montclair
State/Province
California
ZIP/Postal Code
91763
Country
United States
Facility Name
Valley Clinical Trials, Inc.
City
Northridge
State/Province
California
ZIP/Postal Code
91325
Country
United States
Facility Name
Pacific Research Partners, LLC
City
Oakland
State/Province
California
ZIP/Postal Code
94607
Country
United States
Facility Name
National Research Institute
City
Panorama City
State/Province
California
ZIP/Postal Code
91402
Country
United States
Facility Name
Sierra Clinical Research
City
Roseville
State/Province
California
ZIP/Postal Code
95661
Country
United States
Facility Name
Artemis Institute for Clinical Research
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Care Access Research
City
Santa Clarita
State/Province
California
ZIP/Postal Code
91321
Country
United States
Facility Name
Encompass Clinical Research
City
Spring Valley
State/Province
California
ZIP/Postal Code
91978
Country
United States
Facility Name
University Clinical Investigators, Inc.
City
Tustin
State/Province
California
ZIP/Postal Code
92780
Country
United States
Facility Name
Diablo Clinical Research
City
Walnut Creek
State/Province
California
ZIP/Postal Code
94598
Country
United States
Facility Name
Chase Medical Research, LLC
City
Waterbury
State/Province
Connecticut
ZIP/Postal Code
06708
Country
United States
Facility Name
ALL Medical Research, LLC
City
Cooper City
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
Facility Name
Clinical Research of South Florida
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33134
Country
United States
Facility Name
Suncoast Research Group, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Facility Name
New Horizon Research Center
City
Miami
State/Province
Florida
ZIP/Postal Code
33175
Country
United States
Facility Name
Oviedo Medical Research
City
Oviedo
State/Province
Florida
ZIP/Postal Code
32765
Country
United States
Facility Name
Urban Family Practice Associates, PC
City
Marietta
State/Province
Georgia
ZIP/Postal Code
30067
Country
United States
Facility Name
In-Quest Medical Research, LLC- Peachtree Corners
City
Peachtree Corners
State/Province
Georgia
ZIP/Postal Code
30071
Country
United States
Facility Name
Pacific Diabetes & Endocrine Center
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96813
Country
United States
Facility Name
East West Medical Institute
City
Honolulu
State/Province
Hawaii
ZIP/Postal Code
96814
Country
United States
Facility Name
Elite Clinical Trials LLLP
City
Blackfoot
State/Province
Idaho
ZIP/Postal Code
83221
Country
United States
Facility Name
Saltzer Medical Group. P.A.
City
Nampa
State/Province
Idaho
ZIP/Postal Code
83686
Country
United States
Facility Name
Prairie Education and Research Cooperative
City
Springfield
State/Province
Illinois
ZIP/Postal Code
62711
Country
United States
Facility Name
Synexus/Clinical Research Advantage
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47714
Country
United States
Facility Name
Midwest Institute for Clinical Research
City
Indianapolis
State/Province
Indiana
ZIP/Postal Code
46260
Country
United States
Facility Name
Iderc, P.L.C.
City
West Des Moines
State/Province
Iowa
ZIP/Postal Code
50265
Country
United States
Facility Name
InterMed, PA
City
Portland
State/Province
Maine
ZIP/Postal Code
04101
Country
United States
Facility Name
MedStar Health Research Institute
City
Hyattsville
State/Province
Maryland
ZIP/Postal Code
20782
Country
United States
Facility Name
NECCR PrimaCare Research, LLC
City
Fall River
State/Province
Massachusetts
ZIP/Postal Code
02721
Country
United States
Facility Name
Aa Mrc Llc
City
Flint
State/Province
Michigan
ZIP/Postal Code
48504
Country
United States
Facility Name
Troy Internal Medicine, PC
City
Troy
State/Province
Michigan
ZIP/Postal Code
48098
Country
United States
Facility Name
Clinical Research Professionals
City
Chesterfield
State/Province
Missouri
ZIP/Postal Code
63005
Country
United States
Facility Name
StudyMetrix Research, LLC
City
Saint Peters
State/Province
Missouri
ZIP/Postal Code
63303
Country
United States
Facility Name
Montana Health Research
City
Billings
State/Province
Montana
ZIP/Postal Code
59102
Country
United States
Facility Name
Glacier View Research Institute
City
Kalispell
State/Province
Montana
ZIP/Postal Code
59901
Country
United States
Facility Name
Premier Research
City
Trenton
State/Province
New Jersey
ZIP/Postal Code
08611
Country
United States
Facility Name
Manhattan Medical Research
City
New York
State/Province
New York
ZIP/Postal Code
10016
Country
United States
Facility Name
Great Lakes Medical Research
City
Westfield
State/Province
New York
ZIP/Postal Code
14787
Country
United States
Facility Name
Metrolina Internal Medicine, P.A.
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28207
Country
United States
Facility Name
Diabetes & Endocrinology Consultants PC
City
Morehead City
State/Province
North Carolina
ZIP/Postal Code
28557
Country
United States
Facility Name
Aventiv Research
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43213
Country
United States
Facility Name
Intend Research
City
Norman
State/Province
Oklahoma
ZIP/Postal Code
73069
Country
United States
Facility Name
IPS Research Company
City
Oklahoma City
State/Province
Oklahoma
ZIP/Postal Code
73103
Country
United States
Facility Name
The Corvallis Clinic P.C.
City
Corvallis
State/Province
Oregon
ZIP/Postal Code
97330
Country
United States
Facility Name
Summit Research Network Inc
City
Portland
State/Province
Oregon
ZIP/Postal Code
97210
Country
United States
Facility Name
Heritage Valley Medical Group, Inc.
City
Beaver
State/Province
Pennsylvania
ZIP/Postal Code
15009
Country
United States
Facility Name
Detweiler Family Medicine
City
Lansdale
State/Province
Pennsylvania
ZIP/Postal Code
19446
Country
United States
Facility Name
Preferred Primary Care Physicians
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15236
Country
United States
Facility Name
Sudir Bansal M.D. Inc.
City
Warwick
State/Province
Rhode Island
ZIP/Postal Code
02886
Country
United States
Facility Name
PMG Research of Charleston, LLC
City
Moncks Corner
State/Province
South Carolina
ZIP/Postal Code
29461
Country
United States
Facility Name
Chattanooga Research and Medicine (CHARM)
City
Chattanooga
State/Province
Tennessee
ZIP/Postal Code
37404
Country
United States
Facility Name
Dallas Diabetes Endocrine Center
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
Facility Name
Southern Endocrinology and Associates PA
City
Mesquite
State/Province
Texas
ZIP/Postal Code
75149
Country
United States
Facility Name
Consano Clinical Research
City
Shavano Park
State/Province
Texas
ZIP/Postal Code
78231
Country
United States
Facility Name
Martin Diagnostic Clinic
City
Tomball
State/Province
Texas
ZIP/Postal Code
77375
Country
United States
Facility Name
ClinPoint Trials, LLC
City
Waxahachie
State/Province
Texas
ZIP/Postal Code
75165
Country
United States
Facility Name
Progressive Clinical Research
City
Bountiful
State/Province
Utah
ZIP/Postal Code
84010
Country
United States
Facility Name
Advanced Research Institute
City
Ogden
State/Province
Utah
ZIP/Postal Code
84405
Country
United States
Facility Name
Manassas Clinical Research Center
City
Manassas
State/Province
Virginia
ZIP/Postal Code
20110
Country
United States
Facility Name
Clinical Research Partners, LLC
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23235
Country
United States
Facility Name
Capital Clincial Research Center
City
Olympia
State/Province
Washington
ZIP/Postal Code
98502
Country
United States
Facility Name
Walla Walla Clinic
City
Walla Walla
State/Province
Washington
ZIP/Postal Code
99362
Country
United States
Facility Name
Wenatchee Valley Hospital & Clinics
City
Wenatchee
State/Province
Washington
ZIP/Postal Code
98801
Country
United States
Facility Name
Prevea Clinic, Inc
City
Green Bay
State/Province
Wisconsin
ZIP/Postal Code
54303
Country
United States
Facility Name
Centro Medico CICEMO
City
Caba
State/Province
Buenos Aires
ZIP/Postal Code
1405
Country
Argentina
Facility Name
CEDIC-Centro de Investigaciones Clinicas
City
Caba
State/Province
Buenos Aires
ZIP/Postal Code
1425
Country
Argentina
Facility Name
Investigaciones Medicas IMOBA S.R.L.
City
Caba
State/Province
Buenos Aires
ZIP/Postal Code
C1179AAB
Country
Argentina
Facility Name
Centro de Investigaciones Metabólicas (CINME)
City
Ciudad Autonoma de Buenos Aire
State/Province
Buenos Aires
ZIP/Postal Code
C1056ABJ
Country
Argentina
Facility Name
Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada
City
Ciudad Autonoma de Buenos Aire
State/Province
Buenos Aires
ZIP/Postal Code
C1425AGC
Country
Argentina
Facility Name
Centro de Investigacion y Prevencion Cardiovascular (CIPREC)
City
Ciudad Autonoma de
State/Province
Buenos Aires
ZIP/Postal Code
C1119ACN
Country
Argentina
Facility Name
Instituto de Investigaciones Clinicas Mar del Plata
City
Mar del Plata
State/Province
Buenos Aires
ZIP/Postal Code
B7600FZN
Country
Argentina
Facility Name
CIPADI
City
Godoy Cruz
State/Province
Mendoza
ZIP/Postal Code
M5501ARP
Country
Argentina
Facility Name
AXISMED SRL - Bioclinica Research Network
City
Buenos Aires
ZIP/Postal Code
C1430CKE
Country
Argentina
Facility Name
CENUDIAB
City
Ciudad Autonoma de Buenos Aire
ZIP/Postal Code
1408
Country
Argentina
Facility Name
Centro Médico Viamonte
City
Ciudad Autonoma de Buenos Aire
ZIP/Postal Code
C1120AAC
Country
Argentina
Facility Name
Instituto Centenario
City
Ciudad Autonoma de Buenos Aire
ZIP/Postal Code
C1204AAD
Country
Argentina
Facility Name
Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff
City
Ciudad Autonoma de Buenos Aire
ZIP/Postal Code
C1205AAO
Country
Argentina
Facility Name
Mautalen Salud e Investigación - Servicio de Endocrinología
City
Ciudad Autonoma De Buenos Air
ZIP/Postal Code
C1128AAF
Country
Argentina
Facility Name
Instituto Medico Strusberg
City
Cordoba
ZIP/Postal Code
X5000EDC
Country
Argentina
Facility Name
Centro Medico Privado San Vicente Diabetes
City
Cordoba
ZIP/Postal Code
X5006CBI
Country
Argentina
Facility Name
Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC
City
Cordoba
ZIP/Postal Code
X5008HHW
Country
Argentina
Facility Name
Landesklinikum Korneuburg-Stockerau, Standort Stockerau
City
Stockerau
State/Province
Niederösterreich
ZIP/Postal Code
2000
Country
Austria
Facility Name
Universitätsklinikum Graz
City
Graz
State/Province
Steiermark
ZIP/Postal Code
8036
Country
Austria
Facility Name
Ordination Dr. Evelyn Fließer-Görzer
City
Saint Stefan Ob Stainz
State/Province
Steiermark
ZIP/Postal Code
8511
Country
Austria
Facility Name
VIVIT Institut am LKH Feldkirch
City
Feldkirch
State/Province
Vorarlberg
ZIP/Postal Code
6800
Country
Austria
Facility Name
KA Rudolfstiftung
City
Wien
ZIP/Postal Code
1030
Country
Austria
Facility Name
Zentrum für klinische Studien Dr. Ursula Hanusch GmbH
City
Wien
ZIP/Postal Code
1060
Country
Austria
Facility Name
Bailey Clinic
City
Red Deer
State/Province
Alberta
ZIP/Postal Code
T4N 6V7
Country
Canada
Facility Name
Aggarwal and Associates Ltd
City
Brampton
State/Province
Ontario
ZIP/Postal Code
L6T 0G1
Country
Canada
Facility Name
T. Nemtean Medicine Professional Corporation
City
Mississauga
State/Province
Ontario
ZIP/Postal Code
L4Y 2N8
Country
Canada
Facility Name
Bluewater Clinical Research Group Inc
City
Sarnia
State/Province
Ontario
ZIP/Postal Code
N7T 4X3
Country
Canada
Facility Name
Stayner Medical Clinic
City
Stayner
State/Province
Ontario
ZIP/Postal Code
L0M 1S0
Country
Canada
Facility Name
Dr. Anil K. Gupta Medicine Professional Corporation
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M9V 4B4
Country
Canada
Facility Name
Iatriko Palaiou Falirou, Medical Center
City
Palaio Faliro
State/Province
Athens
ZIP/Postal Code
17562
Country
Greece
Facility Name
Laiko General Hospital of Athens
City
Ampelokipoi
State/Province
Attica
ZIP/Postal Code
11527
Country
Greece
Facility Name
Gen Hospital of Athens G Gennimatas
City
Athens
State/Province
Attiki
ZIP/Postal Code
11527
Country
Greece
Facility Name
G.Papanikolaou General Hospital
City
Exohi
State/Province
Thessaloniki
ZIP/Postal Code
57010
Country
Greece
Facility Name
Thermi Clinic
City
Thermi
State/Province
Thessaloniki
ZIP/Postal Code
57001
Country
Greece
Facility Name
Athens Euroclinic
City
Athens
ZIP/Postal Code
11521
Country
Greece
Facility Name
University General Hospital of Larissa
City
Larissa
ZIP/Postal Code
41110
Country
Greece
Facility Name
AHEPA Hospital
City
Thessaloniki
ZIP/Postal Code
54636
Country
Greece
Facility Name
Ippokrateio General Hospital of Thessaloniki
City
Thessaloniki
ZIP/Postal Code
54639
Country
Greece
Facility Name
Euromedica - General Clinic of Thessaloniki
City
Thessaloniki
ZIP/Postal Code
54645
Country
Greece
Facility Name
Studium Egeszseghaz Kft.
City
Kalocsa
State/Province
Bacs-Kiskun
ZIP/Postal Code
6300
Country
Hungary
Facility Name
Kenezy Gyula Korhaz es Rendelointezet
City
Debrecen
State/Province
Hajdu-Bihar
ZIP/Postal Code
4031
Country
Hungary
Facility Name
Grof Esterhazy Korhaz es Rendelointezeti Szakrendelo
City
Papa
State/Province
Veszprem
ZIP/Postal Code
8500
Country
Hungary
Facility Name
Szent Margit Rendelointezet
City
Budapest
ZIP/Postal Code
1032
Country
Hungary
Facility Name
ClinDiab Kft.
City
Budapest
ZIP/Postal Code
1089
Country
Hungary
Facility Name
Strazsahegy Medicina Bt.
City
Budapest
ZIP/Postal Code
1171
Country
Hungary
Facility Name
TRANTOR 99 Bt.
City
Budapest
ZIP/Postal Code
1213
Country
Hungary
Facility Name
Kanizsai Dorottya Korhaz
City
Nagykanizsa
ZIP/Postal Code
8800
Country
Hungary
Facility Name
Zala Megyei Szent Rafael Korhaz
City
Zalaegerszeg
ZIP/Postal Code
8900
Country
Hungary
Facility Name
Maccabi Diabetes Clinic, Grand Canyon, North District, Haifa
City
Haifa
ZIP/Postal Code
3299001
Country
Israel
Facility Name
Linn Medical Center
City
Haifa
ZIP/Postal Code
3515209
Country
Israel
Facility Name
Hadassah Medical Center
City
Jerusalem
ZIP/Postal Code
911201
Country
Israel
Facility Name
Meir Medical Center
City
Kfar Saba
ZIP/Postal Code
4428164
Country
Israel
Facility Name
Clalit Health Services - Shuali Clinic
City
Raanana
ZIP/Postal Code
4345204
Country
Israel
Facility Name
ZIV Medical Center
City
Safed
ZIP/Postal Code
13100
Country
Israel
Facility Name
Sakhnin Community Clinic, Clalit Health Services
City
Sakhnin
ZIP/Postal Code
3081000
Country
Israel
Facility Name
Tel Aviv Sourasky Medical Center
City
Tel Aviv Jaffa
ZIP/Postal Code
6423906
Country
Israel
Facility Name
Diabetes Medical Center (DMC)
City
Tel Aviv
ZIP/Postal Code
6148002
Country
Israel
Facility Name
Azienda Ospedaliera Universitaria Careggi
City
Firenze
State/Province
Florence
ZIP/Postal Code
50134
Country
Italy
Facility Name
Istituto Clinico Humanitas
City
Rozzano
State/Province
Milano
ZIP/Postal Code
20089
Country
Italy
Facility Name
A.O.U. Senese Policlinico Santa Maria alle Scotte
City
Siena
State/Province
SI
ZIP/Postal Code
53100
Country
Italy
Facility Name
Azienda Ospedaliera Papa Giovanni XXIII
City
Bergamo
ZIP/Postal Code
24127
Country
Italy
Facility Name
Policlinico Mater Domini
City
Catanzaro
ZIP/Postal Code
88100
Country
Italy
Facility Name
Fondazione Universitaria degli Studi G D'Annunzio
City
Chieti
ZIP/Postal Code
66100
Country
Italy
Facility Name
Ospedale Santa Maria Goretti
City
Latina
ZIP/Postal Code
04100
Country
Italy
Facility Name
Policlinico Giaccone
City
Palermo
ZIP/Postal Code
90127
Country
Italy
Facility Name
Ospedale Civile Maggiore Borgo Trento
City
Verona
ZIP/Postal Code
37126
Country
Italy
Facility Name
Hospital Univ. Dr. Jose Eleuterio Gonzalez
City
Monterrey
State/Province
Nuevo León
ZIP/Postal Code
64460
Country
Mexico
Facility Name
Investigacion en Salud y Metabolismo S.C
City
Chihuahua
ZIP/Postal Code
31217
Country
Mexico
Facility Name
NZOZ ZDROWIE Osteo-Medic
City
Bialystok
ZIP/Postal Code
15-351
Country
Poland
Facility Name
Poradnia Diabetologiczna SN ZOZ Lege Artis
City
Bialystok
ZIP/Postal Code
15-404
Country
Poland
Facility Name
NS ZOZ Osrodek Diabetologiczny " Popula"
City
Bialystok
ZIP/Postal Code
15-445
Country
Poland
Facility Name
Centrum Badan Klinicznych, PI House
City
Gdansk
ZIP/Postal Code
80-546
Country
Poland
Facility Name
NZOZ Salvia s.c.
City
Katowice
ZIP/Postal Code
40-772
Country
Poland
Facility Name
NZOZ Diab-Endo-Met
City
Krakow
ZIP/Postal Code
31-261
Country
Poland
Facility Name
Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A.
City
Lodz
ZIP/Postal Code
90-242
Country
Poland
Facility Name
Gabinety Terpa
City
Lublin
ZIP/Postal Code
20-333
Country
Poland
Facility Name
NZOZ Przychodnia Specjalistyczna MEDICA
City
Lublin
ZIP/Postal Code
20-538
Country
Poland
Facility Name
Centrum Medyczne OMEDICA
City
Poznan
ZIP/Postal Code
60-111
Country
Poland
Facility Name
Praktyka Lekarska
City
Poznan
ZIP/Postal Code
61-655
Country
Poland
Facility Name
Nzoz Neuro - Kard
City
Poznan
ZIP/Postal Code
61-853
Country
Poland
Facility Name
NZOZ Przychodnia Specjalistyczna Henryk RudzkiAndrzej Wittek
City
Ruda Slaska
ZIP/Postal Code
41-709
Country
Poland
Facility Name
Centralny Szpital Kliniczny MSW
City
Warszawa
ZIP/Postal Code
02-507
Country
Poland
Facility Name
Regionalna Poradnia Diabetologiczna
City
Wroclaw
ZIP/Postal Code
50-127
Country
Poland
Facility Name
Research and Cardiovascular Corp.
City
Ponce
ZIP/Postal Code
00717
Country
Puerto Rico
Facility Name
Clinical Research Puerto Rico, Inc.
City
San Juan
ZIP/Postal Code
00909
Country
Puerto Rico
Facility Name
GCM Medical Group PSC
City
San Juan
ZIP/Postal Code
00917
Country
Puerto Rico
Facility Name
Office: Dr. Luis Rivera Colon
City
San Juan
ZIP/Postal Code
00921
Country
Puerto Rico
Facility Name
S. C. Grandmed S.R.L., Str.
City
Oradea
State/Province
Bihor
ZIP/Postal Code
410159
Country
Romania
Facility Name
SC Gama Diamed SRL
City
Mangalia
State/Province
Constanta
ZIP/Postal Code
905500
Country
Romania
Facility Name
Spitalul Judetean de Urgenta Satu Mare
City
Satu-Mare
State/Province
Jud Satu-Mare
ZIP/Postal Code
440055
Country
Romania
Facility Name
CMI DNBM Dr. Pop Lavinia
City
Baia Mare
State/Province
Maramures
ZIP/Postal Code
430222
Country
Romania
Facility Name
Cosamext SRL
City
Targu Mures
State/Province
Mures
ZIP/Postal Code
540098
Country
Romania
Facility Name
SC Diabmed Dr Popescu Alexandrina SRL
City
Ploiesti
State/Province
Prahova
ZIP/Postal Code
100163
Country
Romania
Facility Name
SC Dianutrilife Medica SRL
City
Ploiesti
State/Province
Prahova
ZIP/Postal Code
100561
Country
Romania
Facility Name
Centrul Medical Dr. Negrisanu
City
Timisoara
State/Province
Timis
ZIP/Postal Code
300456
Country
Romania
Facility Name
Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL
City
Brasov
ZIP/Postal Code
500283
Country
Romania
Facility Name
Cabinetul Medical Nicodiab SRL
City
Bucharest
ZIP/Postal Code
010507
Country
Romania
Facility Name
Easydiet SRL
City
Bucuresti
ZIP/Postal Code
010627
Country
Romania
Facility Name
SC Nutrilife SRL
City
Bucuresti
ZIP/Postal Code
013682
Country
Romania
Facility Name
SC Medcon SRL
City
Buzau
ZIP/Postal Code
120203
Country
Romania
Facility Name
Centrul Medical Unirea SRL
City
Cluj Napoca
ZIP/Postal Code
400349
Country
Romania
Facility Name
Cabinet Medical Urodiamed S.R.L.
City
Craiova
ZIP/Postal Code
200349
Country
Romania
Facility Name
Milena Sante SRL
City
Galati
ZIP/Postal Code
800001
Country
Romania
Facility Name
SC Olimpia Med SRL
City
Iasi
ZIP/Postal Code
700400
Country
Romania
Facility Name
Arkhangelsk Regional Clinical Hospital
City
Arkhangelsk
ZIP/Postal Code
163045
Country
Russian Federation
Facility Name
Arkhangelsk the first city clinical hospital
City
Arkhangelsk
ZIP/Postal Code
163045
Country
Russian Federation
Facility Name
Rostov State Medical University
City
Rostov-on-Don
ZIP/Postal Code
344022
Country
Russian Federation
Facility Name
City Hospital of Saint Martyr Elizabeth
City
Saint Petersburg
ZIP/Postal Code
193257
Country
Russian Federation
Facility Name
SPb GUZ "Diagnostic Center #85"
City
Saint Petersburg
ZIP/Postal Code
198255
Country
Russian Federation
Facility Name
Regional Clinical Hospital
City
Saratov
ZIP/Postal Code
410053
Country
Russian Federation
Facility Name
Human care s.r.o.
City
Kosice
State/Province
Slovak Republic
ZIP/Postal Code
04012
Country
Slovakia
Facility Name
MediVet s.r.o.
City
Malacky
State/Province
Slovak Republic
ZIP/Postal Code
90101
Country
Slovakia
Facility Name
Areteus s.r.o.
City
Trebisov
State/Province
Slovak Republic
ZIP/Postal Code
07501
Country
Slovakia
Facility Name
Diacrin s.r.o.
City
Bratislava
ZIP/Postal Code
84102
Country
Slovakia
Facility Name
Noemis, s.r.o.
City
Nove Mesto nad Vahom
ZIP/Postal Code
91501
Country
Slovakia
Facility Name
FUNKYSTUFF s.r.o.
City
Nove Zamky
ZIP/Postal Code
94001
Country
Slovakia
Facility Name
MUDr. Jan Culak, s.r.o.
City
Prievidza
ZIP/Postal Code
97101
Country
Slovakia
Facility Name
DIA-MED CENTRUM s.r.o.
City
Puchov
ZIP/Postal Code
02001
Country
Slovakia
Facility Name
Tatratrial s.r.o.
City
Roznava
ZIP/Postal Code
04801
Country
Slovakia
Facility Name
Hospital Infanta Luisa
City
Sevilla
State/Province
Andalucía
ZIP/Postal Code
41010
Country
Spain
Facility Name
Corporació Sanitaria Parc Tauli
City
Sabadell
State/Province
Barcelona
ZIP/Postal Code
08208
Country
Spain
Facility Name
Hospital Universitario Marques De Valdecilla
City
Santander
State/Province
Cantabria
ZIP/Postal Code
39011
Country
Spain
Facility Name
Clinica Juaneda
City
Palma de Mallorca
State/Province
Islas Baleares
ZIP/Postal Code
07014
Country
Spain
Facility Name
Hospital Universitario Quiron Madrid
City
Pozuelo de Alarcon
State/Province
Madrid
ZIP/Postal Code
28223
Country
Spain
Facility Name
Instituto de Ciencias medicas
City
Alicante
ZIP/Postal Code
03004
Country
Spain
Facility Name
Clinica San Pedro
City
Almeria
ZIP/Postal Code
04001
Country
Spain
Facility Name
Centre Medico Teknon
City
Barcelona
ZIP/Postal Code
08022
Country
Spain
Facility Name
Hospital Clinico Universitario San Cecilio
City
Granada
ZIP/Postal Code
18012
Country
Spain
Facility Name
Virgen de Las Nieves
City
Granada
ZIP/Postal Code
18014
Country
Spain
Facility Name
Centro Especialidades San Jose Obrero (Barbarela)
City
Malaga
ZIP/Postal Code
29006
Country
Spain
Facility Name
Hospital Universitario Virgen Macarena
City
Sevilla
ZIP/Postal Code
41009
Country
Spain
Facility Name
Clinica Nuevas Tecnologias en Diabetes y Endocrinologia
City
Seville
ZIP/Postal Code
41003
Country
Spain
Facility Name
Policlinica Galileo
City
Teruel
ZIP/Postal Code
44002
Country
Spain
Facility Name
Chung Shan Medical University Hospital
City
Taichung City
ZIP/Postal Code
40201
Country
Taiwan
Facility Name
Taichung Veterans General Hospital
City
Taichung
ZIP/Postal Code
40705, ROC
Country
Taiwan
Facility Name
Chi-Mei Medical Center
City
Tainan City
ZIP/Postal Code
71004
Country
Taiwan

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.
IPD Sharing Time Frame
Data are available 6 months after the primary publication and approval of the indication studied in the US and EU, whichever is later. Data will be indefinitely available for requesting.
IPD Sharing Access Criteria
A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.
IPD Sharing URL
https://vivli.org/
Citations:
PubMed Identifier
35546790
Citation
Cox DA, Wang H, Nicolay C, Bethel MA. Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study. Diabetes Obes Metab. 2022 Sep;24(9):1770-1778. doi: 10.1111/dom.14762. Epub 2022 May 29.
Results Reference
derived
PubMed Identifier
33397768
Citation
Frias JP, Bonora E, Nevarez Ruiz L, Li YG, Yu Z, Milicevic Z, Malik R, Bethel MA, Cox DA. Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11). Diabetes Care. 2021 Mar;44(3):765-773. doi: 10.2337/dc20-1473. Epub 2021 Jan 4.
Results Reference
derived
Links:
URL
https://www.lillytrialguide.com/en-US/studies/adult-type-2-diabetes/GBGL#?postal=
Description
A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes (AWARD-11)

Learn more about this trial

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

We'll reach out to this number within 24 hrs